布地奈德联合特布他林佐治小儿毛细支气管炎临床观察

Clinical Observation of Budesonide Combined with Terbutaline in the Treatment of Bronchiolitis in Children

目的探讨布地奈德联合特布他林佐治小儿毛细支气管炎临床疗效。方法本次研究对象共82例,均选自本院儿科2016年10月-2017年9月所接收的毛细支气管炎患儿为研究对象,分组采用数字表分组法,将所选取的研究对象分为两组,即治疗组与对照组,所有患儿在入院接受治疗之后,均接受了口服抗组胺药物、静脉注射茶碱类制剂、吸氧以及止咳化痰等常规治疗。对照组患儿接受的治疗方法为单纯使用布地奈德治疗。治疗组患儿接受布地奈德联合特布他林治疗,观察两组治疗效果。结果治疗组患者临床有效率97.56%,显著高于对照组68.29%,有统计学差异(P<0.05)。结论无论是布地奈德,还是特他布林,均是治疗该疾病的有效药物之一,将这两种药物联合使用对患儿进行雾化治疗,在毛细支气管炎中具有一定的临床价值,值得我们推广使用。

Objective To investigate the clinical efficacy of budesonide combined with terbutaline in the treatment of bronchiolitis in children.Methods The subjects in this study were 82 cases,were selected from the pediatric department of our hospital from October 2016 to September 2017 received the bronchiolitis group as the research object,using digital table grouping method,the research object were divided into two groups:treatment group and control group,all patients in the hospital after receiving treatment were given oral antihistamines,intravenous theophylline preparations,oxygen therapy and relieving cough and phlegm and other conventional treatment.The treatment of patients in the control group was only treated with budesonide.The patients in the treatment group were treated with budesonide and terbutaline,and the effects of the two groups were observed.Results The clinical effective rate of the patients in the treatment group was 97.56%,which was significantly higher than that of the control group(68.29%),with a statistically significant difference(P<0.05).Conclusion Either budesonide or budesonide is one of the drugs to treat the disease.The combination of the two drugs is of certain clinical value in the treatment of children with bronchiolitis,and is worthy of promotion.